Lundbeck
HLUN-B.CO
HK$33.51
Share price
-1.53%
Change (1 day)
-10.44%
Change (1 year)
Categories
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.
Revenue for Lundbeck (HLUN-B.CO)
Revenue in 2024 (TTM): HK$24.78 Billion
According to Lundbeck
's latest financial reports the company's current revenue (TTM 
) is HK$24.67 Billion. an increase over the revenue in the year 2023 that were of HK$22.63 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Lundbeck from 2009 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | HK$24.69 B | 9.09% |
| 2023 | HK$22.63 B | 12.18% |
| 2022 | HK$20.17 B | 1.45% |
| 2021 | HK$19.88 B | -6.48% |
| 2020 | HK$21.26 B | 5.02% |
| 2019 | HK$20.24 B | -8.35% |
| 2018 | HK$22.09 B | 6.24% |
| 2017 | HK$20.79 B | 15.68% |
| 2016 | HK$17.97 B | 7.24% |
| 2015 | HK$16.76 B | -8.63% |
| 2014 | HK$18.34 B | -12.73% |
| 2013 | HK$21.02 B | 4.81% |
| 2012 | HK$20.05 B | -12.94% |
| 2011 | HK$23.03 B | 13.48% |
| 2010 | HK$20.30 B | 0.74% |
| 2009 | HK$20.15 B |